2nd Quarter - Termination

AMERICAN THORACIC SOCIETY for AMERICAN THORACIC SOCIETY

Firm
Client
Income
—
Expenses
$144,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
May 27, 2021

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 14, 2021 $122,000 Replaced
2nd Quarter - Termination (this page) Jan 6, 2022 $144,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

research and public health funding

LobbyistCovered position, as disclosed
NUALA MOORE —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA)

Veterans VET

funding for va medical and prosthetics research program

LobbyistCovered position, as disclosed
GARY WARREN EWART —

Contacted: Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE

Foreign Relations FOR

international tb funding

LobbyistCovered position, as disclosed
NUALA MOORE Senior Legislative Representative

Contacted: Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Tobacco TOB

tobacco control

LobbyistCovered position, as disclosed
GARY WARREN EWART Director, ATS Government Relations
NUALA MOORE Senior Legislative Representative

Contacted: SENATE; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES

Clean Air and Water (quality) CAW

air quality

LobbyistCovered position, as disclosed
GARY WARREN EWART Director, ATS Government Relations

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.